ECSP982632A - SOLID PHARMACEUTICAL DOSAGE FORMS - Google Patents
SOLID PHARMACEUTICAL DOSAGE FORMSInfo
- Publication number
- ECSP982632A ECSP982632A ECSP982632A ECSP982632A EC SP982632 A ECSP982632 A EC SP982632A EC SP982632 A ECSP982632 A EC SP982632A EC SP982632 A ECSP982632 A EC SP982632A
- Authority
- EC
- Ecuador
- Prior art keywords
- dosage forms
- pharmaceutical dosage
- solid pharmaceutical
- matrix
- water soluble
- Prior art date
Links
- 239000007787 solid Substances 0.000 title abstract 2
- 239000002552 dosage form Substances 0.000 title 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Dispersiones de partículas sólidas de agentes farmacéuticos en una matriz de un polímero soluble en agua que exhiben buena disolución acuosa y aumento de biodisponibilidad.Solid particle dispersions of pharmaceutical agents in a matrix of a water soluble polymer that exhibit good aqueous dissolution and increased bioavailability.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982632 ECSP982632A (en) | 1998-08-20 | 1998-08-20 | SOLID PHARMACEUTICAL DOSAGE FORMS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982632 ECSP982632A (en) | 1998-08-20 | 1998-08-20 | SOLID PHARMACEUTICAL DOSAGE FORMS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982632A true ECSP982632A (en) | 2000-08-18 |
Family
ID=42043552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982632 ECSP982632A (en) | 1998-08-20 | 1998-08-20 | SOLID PHARMACEUTICAL DOSAGE FORMS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982632A (en) |
-
1998
- 1998-08-20 EC ECSP982632 patent/ECSP982632A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8458101A1 (en) | SOLID PHARMACEUTICAL DOSAGE FORMS | |
| CU23440B7 (en) | PRAMIPEXOL SUSTAINED RELEASE COMPOSITION | |
| ES2545205T3 (en) | Combination of azelastine and ciclesonide | |
| WO2002000167A3 (en) | Modified forms of pharmacologically active agents and uses therefor | |
| AU4989997A (en) | Soluble form osmotic dose delivery system | |
| CR6656A (en) | DOSAGE FORM OF DRUGS DRIVEN BY A HYDROGEL | |
| DOP2001000229A (en) | HYDROGEL ACTIVATED DRUG DOSAGE FORM | |
| BRPI0109198B8 (en) | plaster having a support | |
| PT1183014E (en) | ORAL PHARMACEUTICAL COMPOSITIONS FOR CONTROLLED LIBERATION AND TISSUE DISSIMULATION | |
| DE60334924D1 (en) | ANOTEILCHENGRÖSSE | |
| NO20001042D0 (en) | Ophthalmic delayed release preparations containing water-soluble drugs | |
| DE69726179D1 (en) | PHARMACEUTICAL SUSPENSION SYSTEMS | |
| HUP9904024A3 (en) | Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate | |
| NO996323D0 (en) | Medicinal mixtures for application to mucosa | |
| ATE286715T1 (en) | GASTROINTESTINAL PHARMACEUTICAL COMPOSITION ADHESIVE TO THE MUCOSA | |
| KR950031052A (en) | Sustained Release Dosage Forms of Alfuzosin Hydrochloride | |
| BR0007294A (en) | Improved pharmaceutical formulations | |
| ATE541562T1 (en) | IBUPROFEN SUSPENSION | |
| BR9913135A (en) | Oral formulation | |
| CY1109726T1 (en) | Core core disc | |
| ATE304844T1 (en) | ANTI-INFLAMMATORY PHARMACEUTICAL FORMULATIONS | |
| DK1227797T3 (en) | Pharmaceutical solid dispersion formulations | |
| ECSP982632A (en) | SOLID PHARMACEUTICAL DOSAGE FORMS | |
| BR0314547A (en) | Immediate release dosage form comprising a shell having openings therein | |
| ATE424191T1 (en) | PH INDEPENDENT EXTENDED RELEASE PHARMACEUTICAL FORMULATIONS |